2,957 results match your criteria Mondor Disease


Efficacy, tolerability and safety of low volume bowel preparations in Inflammatory Bowel Diseases: The French multicentre CLEAN study.

J Crohns Colitis 2019 Feb 13. Epub 2019 Feb 13.

Department of Gastroenterology, University Hospital of Besançon, University Bourgogne Franche-Comté, Besançon, France.

Background: Standard high-volume polyethylene glycol (PEG) bowel preparations (PEG-4L) are recommended in inflammatory bowel disease (IBD) patients for colonoscopy. However, low-volume preparations (≤ 2 L of active volume) are often used in clinical practice. The aim of the study was to evaluate efficacy, tolerability and safety of the various bowel preparations in IBD, including low-volume preparations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz040DOI Listing
February 2019

Trauma on a Recently Augmented Breast as a Trigger for Mondor's Disease.

Aesthetic Plast Surg 2019 Feb 19. Epub 2019 Feb 19.

Adella Aesthetic, 15G, Tintyava Str., 1172, Sofia, Bulgaria.

Mondor's disease is the eponym used to describe a self-limited phlebitis or thrombophlebitis of the superficial veins localized mainly on the thoracoabdominal area of the human body. Its clinical manifestation includes painful superficial cords causing skin retraction. This medical condition could be idiopathic, iatrogenic or a manifestation of underlying pathology such as breast cancer and seems to be more common than has been previously thought. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00266-019-01331-7DOI Listing
February 2019

Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience.

Ann Intensive Care 2019 Feb 18;9(1):31. Epub 2019 Feb 18.

Ecole Nationale Vétérinaire d'Alfort (ENVA), Faculté de Médecine de Créteil, EA Dynamyc Université Paris-Est Créteil (UPEC), 8 rue du Général Sarrail, 94010, Créteil, France.

Background: Cirrhosis is not recognised as one of the main risk factors of invasive pulmonary aspergillosis (IPA), although its prevalence is increasing. The aim of our study was to identify factors for IPA in such patients with a positive Aspergillus sp. culture in respiratory samples and to evaluate its impact on outcome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13613-019-0502-2DOI Listing
February 2019

Transcarotid Approach for Transcatheter Aortic Valve Replacement With the Sapien 3 Prosthesis: A Multicenter French Registry.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Lille University Hospital, Lille, France. Electronic address:

Objectives: This study sought to describe the procedural and clinical outcomes of patients undergoing transcarotid (TC) transcatheter aortic valve replacement (TAVR) with the Edwards Sapien 3 device.

Background: The TC approach for TAVR holds the potential to become the optimal alternative to the transfemoral gold standard. Limited data exist regarding safety and efficacy of TC-TAVR using the Edwards Sapien 3 device. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.014DOI Listing
February 2019

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

Gastroenterology 2019 Feb 13. Epub 2019 Feb 13.

AP-HP, Hôpital Jean Verdier, Service d'Hépatologie, Bondy, Université Paris 13, Bobigny et INSERM U1162, Université Paris 5, Paris.

Background & Aims: Management of patients with cirrhosis includes endoscopic screening and surveillance to detect esophageal varices (EV) and prevent bleeding. However, the Baveno VI guidelines recommend avoiding endoscopies for patients with liver stiffness measurements below 20 kPa and platelet counts above 150,000 (favorable Baveno VI status) and endoscopic assessment of patients with higher levels of liver stiffness and platelet counts (unfavorable Baveno VI status). We aimed to validate the Baveno VI guidelines, evaluating outcomes of patients in the ANRS-CO12 CirVir cohort with compensated cirrhosis associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, with or without a sustained response to antiviral therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.11.053DOI Listing
February 2019
1 Read

Extracorporeal Life Support for Severe Acute Chest Syndrome in Adult Sickle Cell Disease: A Preliminary Report.

Crit Care Med 2019 Mar;47(3):e263-e265

Service de Réanimation médicale, DHU A-TVB, Hôpital Henri Mondor, AP-HP, Créteil, France.

Objectives: Extracorporeal life support could be helpful for severe acute chest syndrome in adults sickle cell disease, because of the frequent hemodynamic compromise in this setting, including acute pulmonary vascular dysfunction and right ventricular failure. The aim of this study was to report the extracorporeal life support experience for severe acute chest syndrome in four referral centers in France.

Design: The primary endpoint of this multicentric retrospective study was ICU survival of patients with severe acute chest syndrome managed with extracorporeal life support. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003628DOI Listing
March 2019
3 Reads

Head to Knee: Cranial Neural Crest-Derived Cells as Promising Candidates for Human Cartilage Repair.

Stem Cells Int 2019 15;2019:9310318. Epub 2019 Jan 15.

Laboratory of Molecular Oral Pathophysiology, INSERM UMRS 1138, Cordeliers Research Center, Universites of Paris-Descartes, Pierre and Marie Curie and Paris-Diderot, 15 rue de l'école de médecine, Paris, France.

A large array of therapeutic procedures is available to treat cartilage disorders caused by trauma or inflammatory disease. Most are invasive and may result in treatment failure or development of osteoarthritis due to extensive cartilage damage from repeated surgery. Despite encouraging results of early cell therapy trials that used chondrocytes collected during arthroscopic surgery, these approaches have serious disadvantages, including morbidity associated with cell harvesting and low predictive clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/9310318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350557PMC
January 2019

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Lancet 2019 Feb 11. Epub 2019 Feb 11.

AP-HP, Hôpital Cochin, Unité d'Hépatologie, Paris, France; Université Paris Descartes, INSERM U1223 and USM-20, Institut Pasteur, Paris, France.

Background: Although direct-acting antivirals have been used extensively to treat patients with chronic hepatitis C virus (HCV) infection, their clinical effectiveness has not been well reported. We compared the incidence of death, hepatocellular carcinoma, and decompensated cirrhosis between patients treated with direct-acting antivirals and those untreated, in the French ANRS CO22 Hepather cohort.

Methods: We did a prospective study in adult patients with chronic HCV infection enrolled from 32 expert hepatology centres in France. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)32111-1DOI Listing
February 2019
1 Read

Renal toxicities associated with pembrolizumab.

Clin Kidney J 2019 Feb 9;12(1):81-88. Epub 2018 Nov 9.

Department of Pathology, Pitie-Salpetriere Hospital, Paris, France.

Objective: Expanded clinical experience with patients treated by pembrolizumab has accumulated. However, renal toxicities associated with this anti-programmed cell death 1 agent are poorly described because kidney histology is rarely sought. As a nephrology referral centre, we aimed to describe the clinic-biological and histopathological characteristics of pembrolizumab-related nephropathy and its response to treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ckj/sfy100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366307PMC
February 2019
1 Read

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Lancet Infect Dis 2019 Feb 7. Epub 2019 Feb 7.

Haematology Department, Henri Mondor Hospital, Assistance Publique-Hopitaux de Paris, Créteil, France; University Paris-Est Créteil, Créteil, France. Electronic address:

Patients with haematological malignancies are at high risk of infection because of various mechanisms of humoral and cell-mediated immune deficiencies, which mainly depend on underlying disease and specific therapies. Some of these infections are vaccine preventable. However, these malignancies are different from each other, and the treatment approaches are diverse and rapidly evolving, so it is difficult to have a common programme for vaccination in a haematology ward. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14733099183060
Publisher Site
http://dx.doi.org/10.1016/S1473-3099(18)30601-7DOI Listing
February 2019
3 Reads

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Lancet Infect Dis 2019 Feb 7. Epub 2019 Feb 7.

Department of Cellular Therapy and Allogeneneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden.

Infection is a main concern after haemopoietic stem cell transplantation (HSCT) and a major cause of transplant-related mortality. Some of these infections are preventable by vaccination. Most HSCT recipients lose their immunity to various pathogens as soon as the first months after transplant, irrespective of the pre-transplant donor or recipient vaccinations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(18)30600-5DOI Listing
February 2019

Characteristics of Moyamoya Syndrome in Sickle-Cell Disease by Magnetic Resonance Angiography: An Adult-Cohort Study.

Front Neurol 2019 22;10:15. Epub 2019 Jan 22.

Unité des Maladies Génétiques du Globule Rouge, Sickle-Cell Referral Center, Internal Medicine, APHP, Hôpital Henri Mondor, UPEC, Créteil, France.

Sickle cell disease (SCD) can be complicated by moyamoya syndrome. Brain magnetic resonance angiography (MRA) is a non-invasive method to diagnose this syndrome and, steno-occlusion and moyamoya vessels (MMV) scores have been proposed to evaluate its severity. Previous studies of SCD moyamoya syndrome did not evaluate the severity according to MRA scores. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2019.00015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349744PMC
January 2019
1 Read

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.

Int J Oncol 2019 Feb 1. Epub 2019 Feb 1.

Department of Medical Oncology, Franco‑British Institute, 92300 Levallois‑Perret, France.

Aflibercept in combination with 5‑fluorouracil (5‑FU)/irinotecan improves overall survival in the second‑line therapy of patients with metastatic colorectal cancer (mCRC). In this study, we evaluated the effects of aflibercept in first‑line therapy with FOLFOX followed by maintenance with fluoropyrimidine. VELVET was a prospective, single‑arm multicenter phase II study (completed). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2019.4709DOI Listing
February 2019
1 Read

Could Isotretinoin flare Hidradentis suppurativa? A Case Series.

Clin Exp Dermatol 2019 Feb 5. Epub 2019 Feb 5.

Department of Dermatology, Tallaght University Hospital, Tallaght, Dublin 24, Ireland.

We report eight cases of patients with severe acne who were treated with Isotretinoin and developed painful nodules in their axillae and groin consistent with Hidradenitis Suppurativa (HS). The pathogenesis of HS is still not completely understood; recent research from a study in 2011 of biopsies from HS lesions showed a reduction or absence of sebaceous glands compared to normal skin in HS patients and the author suggested this contributes to the pathogenesis of the disease Interestingly the main effect of Isotretinoin is to decrease the size and action of sebaceous glands; so hypothetically, as Isotretinoin acts by reducing the sebaceous glands further it could potentially aggravate the condition. Our experience has instilled caution in our prescribing of Isotretinoin; patients are questioned about symptoms of HS prior to and during treatment, particularly patients with acne conglobata. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ced.13944DOI Listing
February 2019

Schizophrenia risk factors in exceptional achievers: a re-analysis of a 60-year-old database.

Sci Rep 2019 Feb 4;9(1):1294. Epub 2019 Feb 4.

AP-HP, Pôle de Psychiatrie des Hôpitaux Universitaires H Mondor, Créteil, F94000, France.

Current medical research has focused on diseases and their associated risk factors. As such, these factors are assumed to have a deleterious effect. An alternative hypothesis is that some of these risk factors would also increase the chance for an opposite, positive outcome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-37484-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362112PMC
February 2019
1 Read

Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.

JAMA Pediatr 2019 Feb 4. Epub 2019 Feb 4.

Association Clinique et Thérapeutique Infantile du Val-de-Marne, St Maur-des-Fossés, France.

Importance: In several countries, 5 years after 13-valent pneumococcal conjugate vaccine (PCV13) implementation, serotype replacement has been reported for invasive pneumococcal disease, which raises concerns about the long-term outcome of PCV13 implementation. The long-term effect of vaccination on community-acquired pneumonia (CAP) remains unknown.

Objective: To assess the long-term outcome of PCV13 implementation on CAP in children. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapediatrics.2018.5273DOI Listing
February 2019
1 Read

Commentary to "A 44-year old female with familial Mediterranean fever, cardiomyopathy, and end stage renal disease" by Magaki et al.

Brain Pathol 2019 Feb 1. Epub 2019 Feb 1.

Pathology, Tenon Hospital, Paris, France.

We would like to comment on the "Case of the Month" by Magaki et al, entitled "A 44-year old female with familial Mediterranean fever, cardiomyopathy, and end stage renal disease" (3). In this case report, the authors describe the autopsy findings in a patient with systemic AA amyloidosis secondary to familial Mediterranean fever. The patient also had cardiomyopathy with severely reduced left ventricular ejection and death due to cardiac arrest; however, no details about cardiovascular risk factors, cardiac pre-mortem explorations, and heart gross examination were provided. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bpa.12712DOI Listing
February 2019
1 Read

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

JAMA Oncol 2019 Jan 31. Epub 2019 Jan 31.

Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France.

Importance: Androgen-deprivation therapy (ADT) plus docetaxel is the standard of care in hormone-naive metastatic prostate cancer but is of uncertain benefit in a nonmetastatic, high-risk prostate cancer setting.

Objective: To assess the benefit of ADT plus docetaxel in patients presenting with rising prostate-specific antigen (PSA) levels after primary local therapy and high-risk factors but no evidence of metastatic disease.

Design, Setting, And Participants: This open-label, phase 3, randomized superiority trial comparing ADT plus docetaxel vs ADT alone enrolled patients from 28 centers in France between June 4, 2003, and September 25, 2007; final follow-up was conducted April 12, 2017, and analysis was performed May 2 to July 31, 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.6607DOI Listing
January 2019
1 Read

Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.

Catheter Cardiovasc Interv 2019 Jan 31. Epub 2019 Jan 31.

Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France.

Aims: Same-day discharge (SDD) after percutaneous coronary intervention (PCI) was safe and cost-effective in randomized and observational studies but faces limited acceptance due to concerns about early adverse events. Our aim was to evaluate early outcomes after SDD PCI in a high-volume urban PCI center over 10 years.

Methods And Results: From 2007 to 2016, 1,635 unselected patients had PCI at our ambulatory cardiac care unit, mainly for stable ischemic heart disease (SIHD). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28084DOI Listing
January 2019
2 Reads

Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Leukemia 2019 Jan 30. Epub 2019 Jan 30.

Department of Hematology, University Hospitals Leuven, Leuven, Belgium.

A multitude of new agents for the treatment of hematologic malignancies has been introduced over the past decade. Hematologists, infectious disease specialists, stem cell transplant experts, pulmonologists and radiologists have met within the framework of the European Conference on Infections in Leukemia (ECIL) to provide a critical state-of-the-art on infectious complications associated with immunotherapeutic and molecular targeted agents used in clinical routine. For brentuximab vedotin, blinatumomab, CTLA4- and PD-1/PD-L1-inhibitors as well as for ibrutinib, idelalisib, HDAC inhibitors, mTOR inhibitors, ruxolitinib, and venetoclax, a detailed review of data available until August 2018 has been conducted, and specific recommendations for prophylaxis, diagnostic and differential diagnostic procedures as well as for clinical management have been developed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0388-xDOI Listing
January 2019

Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.

HIV Med 2019 Mar 27;20(3):202-213. Epub 2019 Jan 27.

Nephrology and Kidney Transplantation Department, Assistance Publique-Hôpitaux de Paris, Institut Francilien de Recherche en Néphrologie et Transplantation, Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Créteil, France.

Objectives: High rates of clinical acute rejection after kidney transplantation have been reported in people living with HIV (PLHIV), probably as a consequence of drug interactions. We therefore investigated the incidence of acute rejection within 6 months of transplantation in HIV-infected recipients treated with a protease-inhibitor-free raltegravir-based regimen.

Methods: The Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE (NCT01453192) study was a prospective multicentre single-arm trial in adult PLHIV awaiting kidney transplantation, with viral load < 50 HIV-1 RNA copies/mL, CD4 T-cell count > 200 cells/μL, and HIV-1 strains sensitive to raltegravir, aiming to demonstrate 6-month clinical acute rejection rates < 30%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hiv.12700DOI Listing
March 2019
2 Reads

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Am J Hematol 2019 Jan 25. Epub 2019 Jan 25.

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Sickle cell disease (SCD) is the most common monogenic disorder in the world. Notably, there is extensive clinical heterogeneity in SCD that cannot be fully accounted for by known factors, and in particular, the extent to which the phenotypic diversity of SCD can be explained by genetic variation has not been reliably quantified. Here, in a family-based cohort of 449 patients with SCD and 755 relatives, we first show that 5 known modifiers affect 11 adverse outcomes in SCD to varying degrees. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25421
Publisher Site
http://dx.doi.org/10.1002/ajh.25421DOI Listing
January 2019
8 Reads

Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.

Amyloid 2019 Jan 24:1-5. Epub 2019 Jan 24.

o Department of Neurology & Neurobiology of Aging , Kanazawa University Graduate School of Medical Science , Kanazawa , Japan.

Background: Ocular abnormalities have been known to occur in hereditary amyloidotic polyneuropathy since the 1950s. While vitreous opacities and scalloped pupils were described early it has become evident that every component of the eye from the conjunctiva to the retinal vasculature can be involved. Reports from the major centres in Japan, Portugal and Sweden, which primarily treat patients with ATTRV30M, have indicated that with the increased longevity seen in patients treated with liver transplantation the frequency of the more severe eye findings, notably vitreous opacities and subsequent glaucoma, are being detected more frequently. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13506129.2018.1
Publisher Site
http://dx.doi.org/10.1080/13506129.2018.1554563DOI Listing
January 2019
7 Reads

Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression.

Nat Commun 2019 01 23;10(1):391. Epub 2019 Jan 23.

Human Medical Genetics and Genomics Program, University of Colorado School of Medicine, Aurora, 80045, CO, USA.

Vitiligo is an autoimmune disease in which melanocyte destruction causes skin depigmentation, with 49 loci known from previous GWAS. Aiming to define vitiligo subtypes, we discovered that age-of-onset is bimodal; one-third of cases have early onset (mean 10.3 years) and two-thirds later onset (mean 34. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-08337-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344500PMC
January 2019
1 Read
10.742 Impact Factor

genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study.

Heliyon 2019 Jan 7;5(1):e01124. Epub 2019 Jan 7.

INSERM U955, Translational Psychiatry, Créteil, France.

Reports of association of genetic variants of and its receptor () with psychiatric disorders are inconsistent, and there are few population-based studies thus far in bipolar disorder (BD). We genotyped the 1800795 and 2228145 polymorphisms in two independent sets of patients exposed to different environmental stimuli such as climatic conditions or specific infectious burden - a French sample and a south Indian Tamil sample of BD with quantitation of circulating plasma IL-6 levels in the latter sub-sample. In both populations, allele and genotype frequencies did not differ significantly between cases and controls for either polymorphism. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24058440183458
Publisher Site
http://dx.doi.org/10.1016/j.heliyon.2019.e01124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325080PMC
January 2019
3 Reads

Inflammatory Cellular Response to Mechanical Ventilation in Elastase-Induced Experimental Emphysema: Role of Preexisting Alveolar Macrophages Infiltration.

Biomed Res Int 2018 19;2018:5721293. Epub 2018 Dec 19.

INSERM, Unité U955 (Institut Mondor de Recherche Biomédicale), Créteil, 94010, France.

An excessive pulmonary inflammatory response could explain the poor prognosis of chronic obstructive pulmonary disease (COPD) patients submitted to invasive mechanical ventilation. The aim of this study was to evaluate the response to normal tidal volume mechanical ventilation in an elastase-induced murine model of pulmonary emphysema. In this model, two time points, associated with different levels of lung inflammation but similar lung destruction, were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/5721293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313972PMC
December 2018
1 Read

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

Lancet Oncol 2019 Feb 15;20(2):202-215. Epub 2019 Jan 15.

LYSA Imaging, Hôpital H Mondor, Creteil, France.

Background: Increased-dose bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) improves progression-free survival in patients with advanced Hodgkin lymphoma compared with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), but is associated with increased risks of haematological toxicity, secondary myelodysplasia or leukaemia, and infertility. We investigated whether PET monitoring during treatment could allow dose de-escalation by switching regimen (BEACOPP to ABVD) in early responders without loss of disease control compared with standard treatment without PET monitoring.

Methods: AHL2011 is a randomised, non-inferiority, phase 3 study done in 90 centres across Belgium and France. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30784-8DOI Listing
February 2019
4 Reads
24.690 Impact Factor

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

Transl Psychiatry 2019 Jan 17;9(1):20. Epub 2019 Jan 17.

Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.

Early response to first-line antipsychotic treatments is strongly associated with positive long-term symptomatic and functional outcome in psychosis. Unfortunately, attempts to identify reliable predictors of treatment response in first-episode psychosis (FEP) patients have not yet been successful. One reason for this could be that FEP patients are highly heterogeneous in terms of symptom expression and underlying disease biological mechanisms, thereby impeding the identification of one-size-fits-all predictors of treatment response. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41398-018-0366-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336802PMC
January 2019
1 Read

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos-channelopathy: A retrospective series of 126 patients.

Haematologica 2019 Jan 17. Epub 2019 Jan 17.

EA 4666 HEMATIM UPJV and Service Hématologie Biologique, CHU Amiens, France

We describe clinical, hematological and genetic characteristics of a retrospective series of 126 subjects from 64 families with hereditary xerocytosis. Twelve patients from 6 families carried a KCNN4 mutation, 5 recurrent p.Arg352His mutations and one new deletion at the exon 7-intron 7 junction. Read More

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.205328DOI Listing
January 2019
5 Reads

Quality of life in functional movement disorders is as altered as in organic movement disorders.

J Psychosom Res 2019 Jan 12;116:10-16. Epub 2018 Nov 12.

Brain and Spine Institute, UPMC UMRS 1127, INSERM U1127, CNRS UMR 7225, Paris, France; Department of Neurology, Avicenne University Hospital, Paris - Seine Saint-Denis University Hospitals, Bobigny, France.

Objective: Patients with functional movement disorders (FMD) often report a disability and psychiatric comorbidities. However, few studies have compared these aspects in FMD and in organic movement disorders (OMD). The objectives were to compare QoL and psychiatric comorbidities of FMD and OMD patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychores.2018.11.006DOI Listing
January 2019
2 Reads

Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians.

J Comp Eff Res 2019 Jan 16. Epub 2019 Jan 16.

Rouen University Hospital, Epidemiology & Health Promotion Department, Hôpital Charles Nicolle. 1, rue de Germont, 76 031 Cedex Rouen, France.

Aim: The objective was to investigate factors influencing patients' willingness to pay (WTP) and physician's views on the cost of therapy for two contrasted chronic diseases, chronic heart failure and psoriasis.

Methods: A cross-sectional survey was conducted in ten developing countries, using a stated WTP contingent valuation method. Multivariate analyses were performed by linear regression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2018-0106DOI Listing
January 2019

Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data.

Arthritis Res Ther 2019 Jan 15;21(1):22. Epub 2019 Jan 15.

Centre de rhumatologie, CHU de Toulouse, UMR 1043, CPTP, Inserm, Université Paul Sabatier Toulouse III, Toulouse, France.

Background: To investigate the association between 12 single nucleotide polymorphisms (SNPs) located on ERAP1 and IL23R with the presence of inflammation on the sacroiliac joint (SIJ) or spinal magnetic resonance imagery (MRI) in an early onset spondyloarthritis (SpA) cohort.

Methods: All the patients included in the DESIR cohort with an axial SpA and available DNA at baseline were enrolled in this study (n = 645 patients) and underwent a clinical examination, CRP assay, SIJ and spinal MRI scans. Six SNPs located on ERAP1 (rs30187, rs27044, rs27434, rs17482078, rs10050860, rs2287987) and six SNPs located on IL23R (rs1004819, rs10489629, rs1343151, rs2201841, rs10889677, rs11209032) were genotyped. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1807-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332609PMC
January 2019
2 Reads

Mortality and Predictors of Death Poststroke: Data from a Multicenter Prospective Cohort of Lebanese Stroke Patients.

J Stroke Cerebrovasc Dis 2019 Jan 9. Epub 2019 Jan 9.

Department of Neurology, Henri Mondor Hospital AP-HP, Creteil, France.

Background: Despite efforts to reduce stroke mortality rates, the disease remains a leading cause of death in Lebanon highlighting the importance of understanding risk factors and subsequent mortality. We examined mortality rates during the first year after acute stroke and the major short-term (1-month) and long-term (1-year) mortality predictors.

Methods: Data were collected prospectively on hospitalized stroke patients from 8 hospitals in Beirut during a 1-year period. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10523057183068
Publisher Site
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.11.033DOI Listing
January 2019
13 Reads
1.993 Impact Factor

Oral manifestations of sickle cell disease.

Br Dent J 2019 Jan;226(1):27-31

Henri Mondor Hospital, Dental Department, Paris-Descartes University, Ile-de France, France.

Sickle cell disease is one of the most common autosomal recessive genetic diseases. It gives rise to abnormally shaped red blood cells with altered function, the primary clinical features being haemolytic anaemia and vascular occlusion. Acute complications are frequent and variable and include chest syndrome, stroke, infection mainly due to asplenia, bone pain and priapism. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/sj.bdj.2019.4
Publisher Site
http://dx.doi.org/10.1038/sj.bdj.2019.4DOI Listing
January 2019
12 Reads

From the microscope to the magnet: Disconnection in schizophrenia and bipolar disorder.

Neurosci Biobehav Rev 2019 Jan 7;98:47-57. Epub 2019 Jan 7.

INSERM U955, Team 15 "Translational Psychiatry", Hôpitaux Universitaires Mondor, Créteil, France; Fondation Fondamental, Créteil, France; NeuroSpin Neuroimaging Center, UNIACT Lab, Psychiatry Team, CEA Saclay, France.

White matter (WM) abnormalities have implicated schizophrenia (SZ) and bipolar disorder (BD) as disconnection syndromes, yet the extent to which these abnormalities are shared versus distinct remains unclear. Diffusion tensor imaging (DTI) studies yield a putative measure of WM integrity while neuropathological studies provide more specific microstructural information. We therefore systematically reviewed all neuropathological (n = 12) and DTI (n = 11) studies directly comparing patients with SZ and BD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neubiorev.2019.01.005DOI Listing
January 2019
2 Reads

Vitamin D: part II; cod liver oil, ultraviolet radiation, and eradication of rickets.

Int Orthop 2019 Jan 9. Epub 2019 Jan 9.

Hôpital Henri Mondor, 94010, Creteil, France.

Purpose: After Glisson's description of rickets, it took two centuries to realize that rickets was due to the absence of antirachitic nutrients in the diet or lack exposure of the skin to ultraviolet rays. This bone disease caused by vitamin D deficiency was one of the most common diseases of children 100 years ago. This paper explores how the definition, diagnosis, and treatment of rickets shifted in the first decades of the twentieth century. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00264-019-04288-zDOI Listing
January 2019
4 Reads

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort.

Clin Exp Rheumatol 2018 Dec 19. Epub 2018 Dec 19.

Paris Descartes University Department of Rheumatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, and INSERM U1153, Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.

Objectives: We aimed to describe the prevalence and characteristics of peripheral enthesitis in recent onset axial spondyloarthritis, estimate the incidence of peripheral enthesitis over time, and determine the factors associated with the presence of peripheral enthesitis.

Methods: 708 patients with recent onset axial spondyloarthritis were enrolled in the DESIR cohort ( prospective multi-centre, longitudinal). Data regarding the patients and spondyloarthritis characteristics at baseline with a specific focus on enthesitis and occurrence of peripheral enthesitis were collected during the five years of follow-up. Read More

View Article

Download full-text PDF

Source
December 2018
1 Read

Hospitalisation and life support in the year before and during heart transplantation: a French national study.

Open Heart 2018 9;5(2):e000913. Epub 2018 Dec 9.

Département d'Etudes sur les Pathologies et les Patients (DEPP), Caisse Nationale d'Assurance Maladie, Paris, France.

Objective: The objective of this study was to define the characteristics of hospital care use during the year prior to heart transplantation.

Methods: A retrospective cohort of heart transplant recipients registered on the national hospital discharge database between 2010 and 2015 was analysed.

Results: In this cohort of 2379 heart transplant recipients (mean age: 48 years, 74% men), 91% had been admitted at least once, for at least 1 day, to a short-stay hospital during the year before transplantation (mean: 4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2018-000913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307614PMC
December 2018
1 Read

Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study.

Ann Intensive Care 2019 Jan 5;9(1). Epub 2019 Jan 5.

Medical ICU, Saint-Louis Teaching Hospital, 1 Avenue Claude Vellefaux, 75010, Paris, France.

Background: Although outcomes of critically ill patients with haematological malignancies (HMs) have been fully investigated in terms of organ failure and mortality, data are scarce on health-related quality of life (HRQOL) in this population. We aim to assess post-intensive care unit (ICU) burden and HRQOL of critically ill patients with HMs and to identify risk factors for quality-of-life (QOL) impairment.

Results: In total, 1011 patients with HMs who required ICU admission in 17 ICUs in France and Belgium were included in the study; 278 and 117 patients were evaluated for QOL at 3 months and 1 year, respectively, after ICU discharge. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13613-018-0478-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320707PMC
January 2019

Predisposing factors for anti-D immune response in D patients with chronic liver disease transfused with D platelet concentrates.

Transfusion 2019 Jan 3. Epub 2019 Jan 3.

Etablissement Français du Sang Ile de France, Hôpital Henri Mondor, Créteil, France.

Background: Recent reports have indicated that the risk of anti-D alloimmunization following D-incompatible platelet (PLT) transfusion is low in hematology and oncology patients. We investigated the rate of anti-D alloimmunization in RhD-negative (D ) patients with chronic liver disease transfused with D platelet concentrates (PCs) and the factors involved, at a liver transplant (LT) center.

Study Design And Methods: We reviewed the blood bank database from January 2003 to October 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15129DOI Listing
January 2019
10 Reads

[Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation].

Cancer Radiother 2019 Feb 27;23(1):38-45. Epub 2018 Dec 27.

Département d'oncologie-radiothérapie, institut Curie, 25, rue d'Ulm, 75005 Paris, France.

Purpose: The purpose of this study was to evaluate locoregional control and describe the patterns of locoregional failure in women with breast cancer irradiated by a previously described post-mastectomy highly conformal electron beam radiotherapy technique.

Material And Methods: We included all women irradiated by post-mastectomy highly conformal electron beam radiotherapy technique for non-metastatic breast cancer between 2007 and 2011 in our department. All cases of bilateral breast cancer were excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canrad.2018.04.005DOI Listing
February 2019
4 Reads

Neurophysiological, radiological and neuropsychological evaluation of fatigue in multiple sclerosis.

Mult Scler Relat Disord 2018 Dec 21;28:145-152. Epub 2018 Dec 21.

Service de Physiologie, Explorations Fonctionnelles, Hôpital Henri-Mondor, AP-HP, Créteil, France; EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris-Est-Créteil, Créteil, France; Neurology Division, Lebanese American University Medical Center-Rizk Hospital (LAUMC-RH), Beirut, Lebanon. Electronic address:

Background: Fatigue is a multifactorial symptom frequently reported by multiple sclerosis (MS) patients. To date, the pathophysiology of MS fatigue remains poorly understood and little is known about the relationship between this symptom and various clinical, neuropsychological, neurophysiological and radiological data. The aim of this work is to understand the underlying mechanisms of MS fatigue by means of a multidimensional evaluation. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22110348183055
Publisher Site
http://dx.doi.org/10.1016/j.msard.2018.12.029DOI Listing
December 2018
4 Reads

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Circulation 2019 Jan;139(4):431-443

Department of Public Health and Clinical Medicine, Umeå University, Sweden (O.S.).

Background: Hereditary transthyretin-mediated (hATTR) amyloidosis is a rapidly progressive, multisystem disease that presents with cardiomyopathy or polyneuropathy. The APOLLO study assessed the efficacy and tolerability of patisiran in patients with hATTR amyloidosis. The effects of patisiran on cardiac structure and function in a prespecified subpopulation of patients with evidence of cardiac amyloid involvement at baseline were assessed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035831DOI Listing
January 2019
1 Read

Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals.

World J Gastroenterol 2018 Dec;24(46):5203-5214

Service de Chirurgie Hépatobiliaire et Transplantation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg 67000, France.

Liver transplantation for critically ill cirrhotic patients with acute deterioration of liver function associated with extrahepatic organ failures is controversial. While transplantation has been shown to be beneficial on an individual basis, the potentially poorer post-transplant outcome of these patients taken as a group can be held as an argument against allocating livers to them. Although this issue concerns only a minority of liver transplants, it calls into question the very heart of the allocation paradigms in place. Read More

View Article

Download full-text PDF

Source
http://www.wjgnet.com/1007-9327/full/v24/i46/5203.htm
Publisher Site
http://dx.doi.org/10.3748/wjg.v24.i46.5203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295835PMC
December 2018
6 Reads

Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study.

Dig Liver Dis 2019 Feb 28;51(2):318-320. Epub 2018 Nov 28.

Hôpital privé Jean Mermoz, Lyon, France.

Introduction: Combination of cisplatine and Gemcitabine (CisGem) is the reference 1st line Chemotherapy in patients with advanced biliary cancer. FOLFIRINOX demonstrated an overall survival superiority when compared to gemcitabine in 1st line for patients with metastatic pancreatic adenocarcinoma. Because of similarities between pancreatic and biliary cancers, we proposed a randomized trial comparing mFOLFIRINOX and CisGEm. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.11.018DOI Listing
February 2019
2 Reads

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.

Blood 2019 Feb 21;133(6):576-587. Epub 2018 Dec 21.

Department of Nephrology, CHU Poitiers, Poitiers, France.

Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of B-cell clonal disorders, defined by Congo red negative-deposits of monoclonal light chain (LCDD), heavy chain (HCDD), or both (LHCDD). MIDD is a systemic disorder with prominent renal involvement, but little attention has been paid to the description of extrarenal manifestations. Moreover, mechanisms of pathogenic immunoglobulin deposition and factors associated with renal and patient survival are ill defined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-09-872028DOI Listing
February 2019
1 Read

Network Meta-Analysis of Adjuvant Chemotherapy following Resection of Colorectal Liver Metastases.

Gastrointest Tumors 2018 Sep 25;5(1-2):21-31. Epub 2018 Jul 25.

Department of Hepato-Pancreato-Biliary and Liver Transplant Surgery, Queen Elizabeth University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Objective: Six principal adjuvant chemotherapy treatments (ACTs) are currently available for patients with resected colorectal liver metastases. This meta-analysis was designed to determine the optimal ACT, as evaluated by 2-year disease-free survival (DFS) and 5-year overall survival (OS) rates as well as by hepatic recurrences and adverse events (AEs).

Methods: A systematic literature search of the PubMed, EMBASE, Medline, Cochrane Library, and Google Scholar databases was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288637PMC
September 2018

HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients.

Hepatology 2018 Dec 19. Epub 2018 Dec 19.

AP-HP, Hôpital Henri-Mondor, Public Health Department, 94000 Créteil, AP-HP, Hôpital Henri-Mondor, Clinical Research Unit (URC-Mondor), Université Paris-Est, UPEC, DHU A-TVB, IMRB-EA CEpiA (Clinical Epidemiology and Ageing) Unit EA737694000, Créteil, France.

Introduction: It is widely accepted that HIV infection is a risk factor for increased severity of HCV liver disease. However, owing to better efficacy and safety of cART, and increased access to HCV therapy, whether this condition remains true is still unknown.

Methods: 1,253 HCV mono-infected patients and 175 HIV/HCV co-infected cirrhotic patients, included in two prospective French national cohorts (ANRS CO12 CirVir and CO13 HEPAVIH) were studied. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30400
Publisher Site
http://dx.doi.org/10.1002/hep.30400DOI Listing
December 2018
8 Reads

From Vascular Smooth Muscle Cells to Folliculogenesis: What About Vasorin?

Front Med (Lausanne) 2018 4;5:335. Epub 2018 Dec 4.

EA 2496 Orofacial Pathologies, Imaging and Biotherapies, Dental School Faculty, University Paris Descartes and Life Imaging Platform (PIV), Montrouge, France.

First described in 1988, vasorin (VASN) is a transmembrane glycoprotein expressed during early mouse development, and with a less extent, in various organs and tissues (e.g., kidney, aorta, and brain) postnatally. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2018.00335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288187PMC
December 2018

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC.

Oncotarget 2018 Nov 27;9(93):36603-36612. Epub 2018 Nov 27.

Department of Hematology, CHU Hôtel Dieu, Nantes, France.

Background: Clofarabine has been proved to have higher anti-leukemic myeloid activity compared to fludarabine, a drug extensively used as part of reduced intensity conditioning (RIC) for allogeneic stem cell transplantation (allo-SCT).

Results: Eighty-four patients were included. The majority of patients had acute myeloid leukemia (AML, = 63). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290956PMC
November 2018
2 Reads